statin therapy guidelines

Cardiovascular disease remains the leading cause of death worldwide, and aggressive lipid management remains one of the most effective ways to reduce risk. The latest ACC/AHA dyslipidemia guideline updates (released March 2026) reinforce aggressive LDL-C reduction, emphasize earlier risk assessment, and expand the role of non-statin therapies. For busy clinicians in primary care, cardiology, and […]